From : Graeme Robertson <Graeme.Robertson@gilead.com>
To : Sopo Belkania; Aysan Murtezaoglu <Aysan.Murtezaoglu@gilead.com>
Subject : RE: Report May
Cc : Maia Lagvilava;Sean Barr <Sean.Barr@gilead.com>; Jolene Engelbrecht (Contractor) <Jolene.Engelbrecht@gilead.com>
Received On : 04.06.2018 12:11
Dear Sopo, Thank you for sending over the May report. I am also looking at how we can expedite the supply of Epclusa to you. I would like to propose that we have a TC at your earliest convenience to discuss how we could help facilitate this. Thank you and best wishes Graeme Graeme.A Robertson Senior Director, Africa & CIS Access Operations & Emerging Markets -------------------------------------------------------------------------------------------------------------------------------------------------- Gilead Sciences Europe Ltd . Registered as a limited company in England and Wales . Registered number 05510315 Registered office: South Building . 2 Roundwood Avenue . Stockley Park . Uxbridge . UB11 1AZ . England Telephone: +44(0)208 587 2228 . Mobile: +44(0)7789 268 043 . Fax: +44(0)208 744 6773 -----Original Message----- From: Sopo Belkania [mailto:sbelkania@moh.gov.ge] Sent: 04 June 2018 12:04 To: Graeme Robertson; Aysan Murtezaoglu Cc: Maia Lagvilava Subject: Report May Dear Graeme and Aysan, Hope this email find you well. Please find attached report for May month. Best regards, Sopo Belkania Head of HR Management and International Relations Department Ministry of Labor, Health and Social Affairs of Georgia 144 A.Tsereteli Avenue, 0159, Tbilisi, Georgia Mobile number: +995 599 22 32 32 DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England